TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$16.19 USD
-0.23 (-1.40%)
Updated May 3, 2024 04:00 PM ET
After-Market: $16.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 40% (156 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.63 | 1.69 | 9.99 |
Current Quarter Estimate | -0.05 | 5.88 | 57.00 |
Year Ago Quarter Estimate | -0.34 | 4.88 | 52.54 |
Next Quarter Estimate | -0.03 | 7.06 | 61.00 |
Next Year Estimate | 0.57 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -188.89 | 18.50 | 15.67 |
Next Year | 812.50 | 24.30 | 9.31 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 10.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 71.39 | -13.85 |
Price/Book (MRQ) | 15.49 | 1.90 |
Price/Cash Flow (MRFY) | 187.82 | 10.67 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 14.24% | 12.53% |
Return on Equity (TTM) | 33.79% | 13.71% |
Debt to Equity (MRQ) | NA | 19.86 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.